Entrepreneur series: American-born Carla Meledandri is involved in her first startup commercialising her award-winning nanoparticle science.
Fiona Rotherham Tue, 27 Feb 2018
It has been a long process, says Carla Meledandri, from the first inkling her research could lead to potential commercial applications to co-founding a company selling to the world.
The spin-out company Silventum was set up in September last year to commercialise her novel nanochemistry